Valuation: Fleury S.A.

Capitalization 9.35B 1.8B 1.52B 1.39B 1.32B 2.45B 164B 2.53B 16.03B 6.4B 78.63B 6.76B 6.62B 276B P/E ratio 2025 *
16x
P/E ratio 2026 * 13.8x
Enterprise value 12.72B 2.45B 2.07B 1.89B 1.8B 3.33B 223B 3.45B 21.81B 8.71B 107B 9.2B 9.01B 376B EV / Sales 2025 *
1.54x
EV / Sales 2026 * 1.45x
Free-Float
43.84%
Yield 2025 *
5.97%
Yield 2026 * 6.37%
1 day+1.48%
1 week+4.07%
Current month+3.19%
1 month+10.65%
3 months+8.41%
6 months+20.10%
Current year+14.33%
1 week 16.67
Extreme 16.67
17.24
1 month 15.09
Extreme 15.09
17.31
Current year 14.67
Extreme 14.67
17.31
1 year 10.65
Extreme 10.65
17.31
3 years 10.65
Extreme 10.65
18.96
5 years 10.65
Extreme 10.65
27.11
10 years 6.86
Extreme 6.8619
32.47
Manager TitleAgeSince
Chief Executive Officer 56 2021-05-26
Director of Finance/CFO 65 2021-07-22
Chief Tech/Sci/R&D Officer 50 2006-12-31
Director TitleAgeSince
Director/Board Member 82 -
Director/Board Member 80 2013-04-08
Director/Board Member 59 2021-04-29
Change 5d. change 1-year change 3-years change Capi.($)
+1.48%+4.07%+37.31%+24.19% 1.8B
+0.38%+3.33%+25.19%+396.75% 29.39B
-1.59%-4.21%-24.90%-23.60% 7.73B
-0.86%+2.64%+12.45%+235.93% 5.38B
-3.52%+7.14%+34.87%+586.04% 2.64B
-0.59%+2.03%+5.68%+46.97% 2.66B
-3.53%-3.92%+72.38%-10.24% 2.12B
-2.05%-2.18%-4.67%-64.68% 2.11B
-1.74%+0.60% - - 1.86B
-0.43%-4.34%-15.06%-7.74% 1.48B
Average -1.25%+1.02%+15.92%+131.51% 5.72B
Weighted average by Cap. -0.52%+1.82%+16.47%+258.42%

Financials

2025 *2026 *
Net sales 8.27B 1.59B 1.34B 1.23B 1.17B 2.17B 145B 2.24B 14.18B 5.66B 69.55B 5.98B 5.85B 244B 8.92B 1.72B 1.45B 1.33B 1.26B 2.34B 156B 2.42B 15.3B 6.11B 75.07B 6.45B 6.32B 264B
Net income 589M 114M 95.67M 87.56M 83.19M 154M 10.3B 159M 1.01B 403M 4.95B 426M 417M 17.4B 670M 129M 109M 99.57M 94.61M 175M 11.71B 181M 1.15B 458M 5.63B 484M 474M 19.79B
Net Debt 3.37B 650M 548M 502M 477M 884M 59.02B 914M 5.78B 2.31B 28.37B 2.44B 2.39B 99.69B 3.59B 692M 583M 534M 507M 940M 62.77B 972M 6.15B 2.46B 30.18B 2.59B 2.54B 106B
Logo Fleury S.A.
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services. At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
Employees
28,000
Date Price Change Volume
26-02-12 16.98 R$ +3.10% 12,400
26-02-11 17.15 R$ +1.48% 5,876,200
26-02-10 16.90 R$ -0.24% 1,572,800
26-02-09 16.94 R$ +0.06% 7,419,600
26-02-06 16.93 R$ +0.53% 3,954,600
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
17.15BRL
Average target price
17.39BRL
Spread / Average Target
+1.40%

Quarterly revenue - Rate of surprise